June 1, 2020
Dr. Kenneth Katz covers the following learning objectives for this webinar:
This guide can help healthcare providers better integrate sexual health conversations and recommended preventive services into routine visits with adolescents and adults.
June 20, 2019
Rates of sexually-transmitted diseases (STDs) such as chlamydia trachomatis (CT) and gonorrhea (GC) have reached an all-time high. In the U.S., California leads the nation in reported cases of these STDs. Because persons with CT and GC are often asymptomatic, screening is essential for the early detection and treatment that can prevent reproductive complications including pelvic inflammatory disease (PID), tubal infertility, ectopic pregnancy, and chronic pelvic pain in females and epididymitis in males.
This webinar covers current clinical guidelines for routine and targeted screening, treatment, follow-up, and prevention of CT and GC.
Learning objectives:
Presenters:
Resources:
Don’t forget to swab! Among men who have sex with men, 84% of gonorrhea and chlamydia infections would be missed with urine-only screening1. Make sure your clients are screened for gonorrhea and chlamydia of the throat and rectum.
| What: | Extragenital Screening for Gonorrhea and Chlamydia |
| Where: | Rectum and throat |
| Who: | Men who have sex with men (MSM), transgender women, people living with HIV, and people on PrEP who report having receptive anal and/or oral sex |
| When: | At least annually, or every 3 to 6 months as needed based on exposure |
| Why: | When urine-only screening is performed, up to 90% of rectal gonorrhea and 77% of rectal chlamydia infections remain untreated1. HIV-negative men diagnosed with rectal infections are excellent candidates for PrEP, because they have a high risk of HIV infection |
| How: | Swab specimen (self or clinician-collected swab) |
The California Prevention Training Center supports clinics and providers in implementing rectal and pharyngeal STI screening.
For more information, contact us.
Extragenital Chlamydia and Gonorrhea Among Community Venue–Attending MSM, CDC MMWR
April 11, 2019
CA Department of Public Health, Dear Colleague Letter
February 20, 2019
National Coalition of STD Directors – Extragenital Testing
NYC Department of Health and Mental Hygiene – STI’s Among MSM Protocol Card
Self Swab Instructional Posters:
CDC Recommendations for Laboratory-Based Detection of Gonorrhea and Chlamydia, March 14, 2014
Verification of Patient Self-Collected Extragenital Nucleic Acid Amplification Tests
This algorithm provides recommendations for the evaluation and management of infants <30 days old with in-utero exposure to syphilis
Extragenital (rectum and throat) gonorrhea and chlamydia screening resources for providers, clinics, and patients.
Dr. Christoper Ried, Medical Director of HIV/STD Services for Orange County, demonstrates a sexual health history screening using the 5Ps of taking a sexual history.
Algorithm to evaluate patients for secondary syphilis. Includes sexual history taking and physical exam, diagnostic work-up, treatment and follow-up, and reporting and partner management.
Algorithm to assist in evaluating patients for primary syphilis.
A free, on-demand training for California clinical settings that provides participants with an overview of CA laws that guarantee minors’ right to access confidential sexual health services and the roles that clinical practices and healthcare systems have in ensuring these protections.
